SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
SARS-COV-2 重组受体结合域 (RBD) 可诱导针对 SARS-CoV-2 和 SARS-CoV-1 变异株的中和抗体
期刊:Vaccine
影响因子:4.5
doi:10.1016/j.vaccine.2021.08.081
John Lok Man Law, Michael Logan, Michael A Joyce, Abdolamir Landi, Darren Hockman, Kevin Crawford, Janelle Johnson, Gerald LaChance, Holly A Saffran, Justin Shields, Eve Hobart, Raelynn Brassard, Elena Arutyunova, Kanti Pabbaraju, Matthew Croxen, Graham Tipples, M Joanne Lemieux, D Lorne Tyrrell, Mi